Search for: "Astrazeneca" Results 581 - 600 of 1,246
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 May 2012, 12:22 pm by Bexis
AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352, 1360-66 (11th Cir. 2011) (plaintiff had not pleaded recoverable economic injury); Polk v. [read post]
16 May 2012, 1:51 am by Marie Louise
  Highlights this week included: Losec (Omeprazole) – EU: AstraZeneca fine for misleading patent regulators looks fine, says AG Mazák: AstraZeneca v European Commission (IPKat) Australia: High Court refuses application for special leave to [...] [read post]
16 May 2012, 12:45 am by FDABlog HPM
  Both before and after approving generic versions of SEROQUEL, AstraZeneca sued FDA (see our previous posts here and here). [read post]
15 May 2012, 3:12 pm
457/10 P AstraZeneca AB and AstraZeneca plc v European Commission can be read in full here, The IPKat can't help admire the zeal and zest with which AstraZeneca has fought its corner, first on the question of liability and then on the quantum of the fine. [read post]
9 May 2012, 11:09 am by Seyfarth Shaw LLP
AstraZeneca in finding that the administrative exemption does apply to PSRs, the Seventh Circuit has given the industry’s position a tremendous boost. [read post]
9 May 2012, 11:09 am by Seyfarth Shaw LLP
AstraZeneca in finding that the administrative exemption does apply to PSRs, the Seventh Circuit has given the industry’s position a tremendous boost.  [read post]
29 Apr 2012, 9:35 pm by Patent Docs
Novo Nordisk and the Federal Circuit's decisions in AstraZeneca v. [read post]
24 Apr 2012, 6:34 am by Lorraine Fleck
Bing Patent May Not Only Predict Results, but Also Queries http://zite.to/INFng8 Chinese Wind Patent Case May End Up in Nation’s Highest Court http://zite.to/I8c9NC Richemont mounts the trademark barricades http://zite.to/K4iIuQ Intellectual Property news on Facebook, Krka, Kandi, AstraZeneca: http://zite.to/I8brQf Samsung sues Apple yet again after court issues settlement talks (USA, South Korea) http://zite.to/I8bmfC CIA and http://Justice.gov sites take down by UGNazi Hackers group… [read post]
23 Apr 2012, 12:23 pm by Sara Randazzo
Two transactions announced Monday--Thomson Reuters's $1.25 billion sale of its health care unit to a Veritas Capital affiliate, and AstraZeneca's $1.26 billion acquisition of Ardea Biosciences--generated assignments for Covington & Burling, Sullivan & Cromwell, and Paul Hastings. [read post]
20 Apr 2012, 12:06 am by Tessa Shepperson
The report on how homelessness and health are intertwined was presented to government, Minister of State for Care services Paul Burstow who said; "I very much welcome the research carried out by Depaul UK and AstraZeneca on the health of the young homeless population". [read post]
16 Apr 2012, 1:29 am by FDABlog HPM
District Court are Motions for Summary Judgment filed by FDA and AstraZeneca Pharmaceuticals LP (here and here) concerning FDA’s approval of ANDAs for generic versions of SEROQUEL (quetiapine fumarate) Tablets and the Agency’s decision, discussed in a March 27, 2012 Letter Decision, concerning the scope and applicability of 3-year marketing exclusivity in that case. [read post]
8 Apr 2012, 12:54 pm by Andrew Frisch
AstraZeneca, the Court, relying on Smith, held that plaintiff’s work related to her employer’s general operation because she marketed and advertised its pharmaceutical products. [read post]
3 Apr 2012, 4:38 am
* "Teva Tigers v Astrazeneca Lions - obvious to sustain...? [read post]
29 Mar 2012, 8:42 am
Saltzburg has previous experience mediating drug lawsuits such as the 2010 AstraZeneca Seroquel antipsychotic litigation. [read post]
29 Mar 2012, 7:42 am
A fact that the IPKat omitted to mention in yesterday’s post on Teva and ors v AstraZeneca was the large number of legal teams involved. [read post]
29 Mar 2012, 5:47 am by FDABlog HPM
   On Monday, FDA and AstraZeneca fought over whether FDA must provide “advance notice” or “timely notice” to AstraZeneca of ANDA approvals. [read post]
28 Mar 2012, 6:31 am
The ever-faithful BAILII has delivered into the paws of the IPKat Mr Justice Arnold’s decision of 22 March revoking for obviousness Astrazeneca’s patent on a sustained release formulation of the anti-psychotic drug quetiapine (marketed by Astrazeneca under the trade mark Seroquel). [read post]
26 Mar 2012, 1:43 am by FDABlog HPM
AstraZeneca’s Reply to FDA’s Opposition: “FDA can give AstraZeneca advance notice without implicating [21 C.F.R. [read post]